| Product Code: ETC12463470 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Imatinib Drug Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Imatinib Drug Market - Industry Life Cycle |
3.4 Ireland Imatinib Drug Market - Porter's Five Forces |
3.5 Ireland Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Ireland Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Ireland Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Ireland Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland, leading to a higher demand for imatinib drugs. |
4.2.2 Advancements in healthcare infrastructure and access to quality healthcare services in Ireland. |
4.2.3 Rising awareness about the importance of early diagnosis and treatment of cancer among the population. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of pharmaceutical products in Ireland. |
4.3.2 High costs associated with the development, manufacturing, and distribution of imatinib drugs. |
4.3.3 Competition from other treatment options and therapeutic alternatives in the market. |
5 Ireland Imatinib Drug Market Trends |
6 Ireland Imatinib Drug Market, By Types |
6.1 Ireland Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Ireland Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Ireland Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Ireland Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Ireland Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Ireland Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Ireland Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Ireland Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Ireland Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Ireland Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Ireland Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Ireland Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Ireland Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Ireland Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Ireland Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Ireland Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Ireland Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Ireland Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Ireland Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Ireland Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Ireland Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Ireland Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Ireland Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Ireland Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Ireland Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Ireland Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Ireland Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Ireland Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Ireland Imatinib Drug Market Import-Export Trade Statistics |
7.1 Ireland Imatinib Drug Market Export to Major Countries |
7.2 Ireland Imatinib Drug Market Imports from Major Countries |
8 Ireland Imatinib Drug Market Key Performance Indicators |
8.1 Patient survival rates and improvement in overall health outcomes. |
8.2 Adoption rate of imatinib drugs among healthcare providers and patients. |
8.3 Number of clinical trials and research studies focusing on the efficacy and safety of imatinib drugs in Ireland. |
9 Ireland Imatinib Drug Market - Opportunity Assessment |
9.1 Ireland Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Ireland Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Ireland Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Ireland Imatinib Drug Market - Competitive Landscape |
10.1 Ireland Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Ireland Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here